Cardiovascular & Hematological Disorders-Drug Targets
Title:EDITORIAL (Thematic Issue: Novel Oral Anticoagulation-A Milestone in Anticoagulation History)
Volume: 15 Issue: 2
Author(s): Mustafa Yildiz and Ibrahim Akin
Affiliation:
Export Options
About this article
Cite this article as:
Yildiz Mustafa and Akin Ibrahim, EDITORIAL (Thematic Issue: Novel Oral Anticoagulation-A Milestone in Anticoagulation History), Cardiovascular & Hematological Disorders-Drug Targets 2015; 15 (2) . https://dx.doi.org/10.2174/1871529X1502151209124012
DOI https://dx.doi.org/10.2174/1871529X1502151209124012 |
Print ISSN 1871-529X |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-4063 |
33
2
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Mechanisms of Cardioprotection of Halogenated Agents During Extracorporeal Circulation in Cardiac Surgery
Current Vascular Pharmacology Homocystinuric Patient with Deficient CBS Activity: Pyridoxine Efficacy and Toxicity?
Letters in Drug Design & Discovery Medication-Induced Acute Abdominal Pain: Evaluation with CT Imaging
Current Medical Imaging Antiplatelet Agents and Anticoagulants in Patients with Chronic Kidney Disease - from Pathophysiology to Clinical Practice
Current Pharmaceutical Design Pharmacological Management Options to Prevent and Reduce Ischemic Hemorrhagic Transformation
Current Drug Targets Matrix Metalloproteinases as Drug Targets in Acute Pulmonary Embolism
Current Drug Targets Acute Cardioembolic Cerebral Infarction: Answers to Clinical Questions
Current Cardiology Reviews Pharmacogenetic Modulation of Platelet Inhibition
Current Pharmacogenomics and Personalized Medicine A Very Rare Cerebral Complication of Chemotherapy in a Young Girl: A Difficult Diagnosis
Current Drug Safety Preclinical Safety and Pharmacokinetic Profile of 3K3A-APC, a Novel, Modified Activated Protein C for Ischemic Stroke
Current Pharmaceutical Design The No-Reflow Phenomenon in the Coronary Circulation
Cardiovascular & Hematological Agents in Medicinal Chemistry Imaging Features of Thoracic Manifestations of Behçet’s Disease: Beyond Pulmonary Artery Involvement
Current Medical Imaging Reviewing the Cardiovascular Complications of HIV Infection After the Introduction of Highly Active Antiretroviral Therapy
Current Drug Targets - Cardiovascular & Hematological Disorders Circadian Variation of Cardiovascular Events and Morning Blood Pressure Surge
Vascular Disease Prevention (Discontinued) Protrhombotic Effects of Contraceptives
Current Pharmaceutical Design Central Nervous System Involvement in Pediatric Rheumatic Diseases: Current Concepts in Treatment
Current Pharmaceutical Design Recent Patents on Hypocholesterolemic Therapeutic Strategies: An Update
Recent Advances in DNA & Gene Sequences (Discontinued) COVID-19 Severity: Lung-Heart Interplay
Current Cardiology Reviews Pharmacotherapies to Manage Bone Loss-Associated Diseases: A Quest for the Perfect Benefit-to-Risk Ratio
Current Medicinal Chemistry News in the Indications of Direct Oral Anticoagulants According to the American College of Chest Physicians 2016 Guidelines
Current Drug Metabolism